Join Us at FDD Conclave 2025
#FDDConclave
13-14 June 2025
11:00 AM onwards
Le Meridien Hyderabad
About the Event
Advancements in pharmaceutical sciences and novel technologies are reshaping how drugs are formulated and delivered. Be it artificial intelligence, precision medicine, advanced materials science or digital health technologies, their intervention is creating unprecedented opportunities for therapeutic innovation.
However, true innovation is not just scientific advancement but meaningful improvement in patient outcomes and experiences.
Therefore, FDD Conclave 2025, now in its eight edition, aims to highlight the need to reimagine formulation and drug delivery through the lens of patient needs, experiences and outcomes.
This year, it will focus on formulation and drug delivery strategies which can ensure that innovations translate into tangible benefits for healthcare systems and patients worldwide.
Blueprint for India’s Pharma Industry
FR&D experts and leaders will explore how India can leverage its unique strengths - skilled talent, manufacturing excellence and market understanding - to develop therapeutic solutions that enhance efficacy, compliance, and quality of life across diverse patient populations.
The conclave, through thought-provoking discussions and interactive sessions, will also explore and examine the role of supportive regulatory frameworks, sustainable funding models, talent development and collaborative ecosystems in enabling innovation.
Building on the momentum of previous conclaves, the 2025 edition aims to create a blueprint for India's pharma industry as a global leader in patient-centric therapeutic innovation.
Conclave Highlights
Accelerating OSD innovation
From R&D to market
Biologics and biosimilars
The next leap in patient-centric drug development
Injectable therapies 2.0
Driving patient-friendly parenteral drug delivery
Topical and transdermal drug delivery
The rise of non-invasive therapies
Future-ready formulations
Addressing the challenges of special populations
Beyond the needle
Innovations in painless drug delivery
Key Topics to be covered
Integration of patient insights and preferences in formulation and drug delivery design
Convergence of digital technologies and advanced formulation sciences
Breakthrough approaches to addressing long-standing formulation and drug delivery challenges
Pathways to scale lab innovations into commercial products
Cross-disciplinary partnerships to accelerate therapeutic innovation
Regulatory support for novel formulation and delivery approaches
Get updated on the advancements in India’s pharma formulations and drug delivery sector
Gain insights from thought leaders of the pharma and biotech industries
Discuss the role of formulation and drug delivery in gaining a competitive edge
Demonstrate your pharma formulation capabilities and showcase your innovative solutions
Acquire access to solution providers with cutting-edge technologies
Network with the who's who of the pharma industry
Organised by Express Pharma, FDD Conclave 2025 will be held this year in June 2025, It is 'the' platform for leaders, experts and veterans of FR&D to come together to confer and converse, on the current and future trends in the industry, their growth drivers and the challenges to tackle them as well as form meaningful alliances to fast-track progress.
Speakers
Dr Pavan Bhat
CEO, Inventia Healthcare
Mr Manikandan Ramalingam
Sr VP - R&D, Granules Pharma
Mr Makarand Avachat
Executive VP, Lupin
Dr Ravikumar N
EVP, MSN Laboratories
Dr Ajay Khopade
VP - FR&D, Sun Pharma
Dr Shubhadeep D Sinha
Sr VP, Head- Clinical Development & Medical Affairs (CD&MA)
Dr Ramesh Matur
Sr VP & Head-R&D, Biological E
Dr Pirthipal Singh
Head-R&D, Tirupati Group
Mr Ravindra Agarwal
Sr VP, Mankind Pharma
Dr Sachin Mundade
VP - R&D, Micro Labs
Dr Jayant Karajgi
COO, Shilpa Medicare
Dr Sajeev Chandran
VP, Pharmaceutical R&D, Lupin
Mr Dhairy Sharma
Manager - Business Development (Healthcare Division), Cilicant private limited
Mr Vijay Doshi
MD, Pioma Chemicals
Dr Manish Chawla
VP & Head (R&D), Lotus Pharmaceutical
Dr Ravleen Singh Khurana
MD, Nitika Pharmaceutical Specialities
Dr Rakesh Bhasin
Head-R&D (Formulations), Biocon
Mr Satish Chandra Upadhyay
Associate President, Mankind Pharma
Dr Sukhjeet Singh
Chief scientific Officer, Acme Formulation
Ms Lekhna Ajgaonkar Kumar
Associate Director - Marketing, Lonza Capsules & Health Ingredients
Dr Mallinath S Harwalkar
VP- R&D, Hetero
Dr Amarender Reddy Donthidi
VP & Head - R&D Injectables and Ophthalmics, Amneal Pharmaceuticals
Dr Krishna Bhavanasi
VP - F&D, Torrent Pharmaceuticals
Dr Pratik Kakade
Technical Application Expert, Merck Lifescience
Dr Abhijit Gothoskar
Technical Expert, Sigachi Industries
Dr Sachin Arora
VP & Delivery Manager | Formulation Development Oral Solids - US, EU, CA & Global Markets
Dr Khalid Akhter Ansari
Senior Director, Technical Operations, Rising Pharmaceuticals
Mr Chetan Chennur
Sales and Project Manager, Harro Höfliger
Mr Abhishek Ghongade
Deputy Sales Manager, Harro Höfliger
Dr Ashok Omray
Pharma Consultant
Mr Suresh Pareek
Angel Investor (Pharma)
Dr Sharadsrikar Kotturi
Chief Scientific Officer, Neuland Laboratories
Dr Manoj Kumar Singh
SR VP – Analytical R&D, Micro Labs
Ms Ritu Laddha
Sr VP (F&D), Zydus Lifesciences
Dr Jaya Abraham
Head of R&D - India Subcontinent, Haleon
Dr Pramod Kharwade
VP-Formulation Development, Intas Pharmaceuticals
Dr Kamal Kumar Upadhyay
VP - Head R&D Pharma SGI, Biological E
Dr Vasanthakumar Ramu
VP, Head - R&D - Peptides & Complex API's, Alembic Pharmaceuticals
Mr Murali Jayaraman
Head, Formulation and Drug Product Development, Dr Reddy's Laboratories
Mr Shailesh Umakant Parelkar
Sr Manager- Sales, Romaco India Pvt Ltd
Mr Mathivanan Rajagopal
VP & Head – R&D, Axxlent Pharma Science
Dr Vaibhav Sihorkar
VP & BU Head- Formulation Solutions, Aragen Life Sciences
Mr Bijayananda Sahoo
Frontier Researcher [R&D - Formulations], Alembic Pharmaceuticals
Dr Sumedha Nadkar
Lead – Strategic Scientific Communications, Medrenova
Dr Sandhya Shenoy
AVP - FR&D, MSN Laboratories
Mr Elayaraja Natarajan
VP - R&D, Lyrus Life Sciences
Dr Vinod Arora
Principal Advisor, IGMPI
Mr Balasubramaniam Jagdish
VP - Formulation Development (PDU), Recipharm Pharmaservices
Mr Akil Kadiyavala
GM - Technical Services, Dhara Lifescience
Mr Srinivasan Rajaman
General Manager, Medreich
Mr Ashok Dewangan
General Manager | Transdermal, Encube Ethicals
Dr Praveen Khullar
Executive Director, VerGo Pharma Research Laboratories
Partners
Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.
